Maruho Announces Strategic minority Investment in Sibel Health
Osaka (Japan), September 30, 2025 - Maruho Co., Ltd. ("Maruho"; Head Office: Osaka, Japan, President and CEO, Atsushi Sugita) announces completion of a strategic investment in Sibel Health Inc. ("Sibel Health", Head Office: Chicago, Illinois (USA); CEO, Steve Xu MD).
Under the terms of the agreement, Maruho will deepen its collaboration with Sibel Health as a strategic partner, combining Maruho's expertise in dermatology with Sibel Health's extensive know-how in wearable sensor technology*1, AI-enabled algorithms, and integrated digital health platforms*2. This partnership aims to accelerate the development of digital medical devices for diagnosis and treatment in dermatology.
In July 2024, as part of Maruho's initiatives in digital medical devices for dermatology, Maruho entered into a worldwide collaborative development and commercialization agreement with Sibel Health. The agreement includes co-development and future distribution rights for an innovative, prescription-only digital health technology, which is currently under development by Sibel Health for the measurement and suppression of scratching associated with itch.
Maruho, specializing in dermatology, will continue to contribute to the well-being of patients suffering from skin diseases by expanding its medical device business into diagnostics, treatment, and self-care.
Note
The information contained in this news release in regard to pharmaceutical and developmental products is not intended for the purpose of promotion, advertising or medical advice.
*1:Technology that uses wearable devices to monitor the human body and surrounding environment in real time
*2:Services that enable access to IT resources such as servers and operating systems via the internet
[References]
Maruho and Sibel Health Enter into a Worldwide Collaborative Development and Commercialization Agreement for a New Digital Health Technology for Itch (July 2024)
https://www.maruho.co.jp/english/information/20240701.html
About Sibel HealthSibel Health is an award-winning medical technology company with a mission to deliver Better Health Data for All®. Spun out of the research laboratory of Professor John Rogers, a world-renowned researcher in wearable sensing technology at Northwestern University, Sibel Health is a leading provider of advanced monitoring solutions for clinical trials and clinical care. For more information, please visit us at www.sibelhealth.com and follow us on LinkedIn.
About MaruhoMaruho Co., Ltd. has its head office in Osaka and leads Japan in research and development, manufacturing and commercialization of dermatological products. Founded in 1915, Maruho has 1,620 employees (as of the end of September 2024), and net sales were approximately 86.99 billion yen in its fiscal year ended September 30, 2024. With the mission "More smiles, brighter life for you.", Maruho aims to help realize a society where everyone can live with a smile.
For more information, please visit www.maruho.co.jp/english/
Contact Information: |
Maruho Co., Ltd. Public Relations Group, Corporate Planning Dept. |
Tel:+81-(0)6-6371-8831 |
Fax:+81-(0)6-6371-8679 |
Email:kouhou@mii.maruho.co.jp |
Maruho Announces Strategic minority Investment in Sibel Health